Suppr超能文献

一种在 2D 格式的一锅法中用于药物靶点鉴定的两种稳定性蛋白质组学方法的比较。

A Comparison of Two Stability Proteomics Methods for Drug Target Identification in OnePot 2D Format.

机构信息

Pfizer Worldwide Research and Development, Groton, Connecticut 06340, United States.

出版信息

ACS Chem Biol. 2021 Aug 20;16(8):1445-1455. doi: 10.1021/acschembio.1c00317. Epub 2021 Aug 10.

Abstract

Stability proteomics techniques that do not require drug modifications have emerged as an attractive alternative to affinity purification methods in drug target engagement studies. Two representative techniques include the chemical-denaturation-based SPROX (Stability of Proteins from Rates of Oxidation), which utilizes peptide-level quantification and thermal-denaturation-based TPP (Thermal Proteome Profiling), which utilizes protein-level quantification. Recently, the "OnePot" strategy was adapted for both SPROX and TPP to increase the throughput. When combined with the 2D setup which measures both the denaturation and the drug dose dimensions, the OnePot 2D format offers improved analysis specificity with higher resource efficiency. However, a systematic evaluation of the OnePot 2D format and a comparison between SPROX and TPP are still lacking. Here, we performed SPROX and TPP to identify protein targets of a well-studied pan-kinase inhibitor staurosporine with K562 lysate, in curve-fitting and OnePot 2D formats. We found that the OnePot 2D format provided ∼10× throughput, achieved ∼1.6× protein coverage and involves more straightforward data analysis. We also compared SPROX with the current "gold-standard" stability proteomics technique TPP in the OnePot 2D format. The protein coverage of TPP is ∼1.5 fold of SPROX; however, SPROX offers protein domain-level information, identifies comparable numbers of kinase hits, has higher signal (R value), and requires ∼3× less MS time. Unique SPROX hits encompass higher-molecular-weight proteins, compared to the unique TPP hits, and include atypical kinases. We also discuss hit stratification and prioritization strategies to promote the efficiency of hit followup.

摘要

在药物靶标结合研究中,不需要药物修饰的稳定性蛋白质组学技术已经成为亲和纯化方法的一种有吸引力的替代方法。两种代表性技术包括基于化学变性的 SPROX(氧化蛋白稳定性),它利用肽级定量和基于热变性的 TPP(热蛋白质组谱分析),利用蛋白质级定量。最近,“OnePot”策略被应用于 SPROX 和 TPP,以提高通量。当与测量变性和药物剂量两个维度的 2D 方案结合使用时,OnePot 2D 格式提供了更高的资源效率和更高的分析特异性。然而,OnePot 2D 格式的系统评估以及 SPROX 和 TPP 之间的比较仍然缺乏。在这里,我们使用 K562 裂解物进行了 SPROX 和 TPP 实验,以鉴定一种研究充分的泛激酶抑制剂 staurosporine 的蛋白质靶标,采用了曲线拟合和 OnePot 2D 格式。我们发现,OnePot 2D 格式提供了约 10 倍的通量,实现了约 1.6 倍的蛋白质覆盖率,并且涉及更简单的数据分析。我们还将 SPROX 与当前的“金标准”稳定性蛋白质组学技术 TPP 在 OnePot 2D 格式下进行了比较。TPP 的蛋白质覆盖率约为 SPROX 的 1.5 倍;然而,SPROX 提供了蛋白质结构域级别的信息,识别了可比数量的激酶命中,具有更高的信号(R 值),并且需要约 3 倍的 MS 时间。与 TPP 的独特命中相比,SPROX 的独特命中涵盖了更高分子量的蛋白质,包括非典型激酶。我们还讨论了命中分层和优先级策略,以提高命中后续的效率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验